Tech & Pharma

Aegerion Conducts Phase III Trial For Anti-Cholesterol Drug Aegerion Conducts Phase III Trial For Anti-Cholesterol Drug
  • April 16th, 2014
  • The clinical trial will test the efficacy of lomitapide as an adjunct treatment to reduce low-density lipoprotein cholesterol (LDL-C) in patients suffering from homozygous familial hypercholesterolemia.

» Read More...

Tech & Pharma

Aegerion Conducts Phase III Trial For Anti-Cholesterol Drug

Aegerion Conducts Phase III Trial For Anti-Cholesterol Drug

The clinical trial will test the efficacy of lomitapide as an adjunct treatment to reduce low-density lipoprotein cholesterol (LDL-C) in patients suffering from homozygous familial hypercholesterolemia.

Alcon Opens US$160 Million Facility In Singapore

Alcon Opens US$160 Million Facility In Singapore

The 330,000 square foot facility will allow Alcon to rapidly respond to the needs of consumers in Asia.

Bosch Packaging Expands Capacity In Japan

Bosch Packaging Expands Capacity In Japan

Bosch has invested US$2.2 million in the larger Musashi site to meet the demand for pharmaceutical inspection technologies.

University Of Queensland Spinoff Attracts US$45 Million

University Of Queensland Spinoff Attracts US$45 Million

Spinifex Pharmaceuticals will use the investment to run clinical trials for EMA401, an oral treatment for pain that has been shown not to have central nervous system side effects.

China Most Attractive Market For Clean Energy

China Most Attractive Market For Clean Energy

China received the most investment for renewable energies in 2013, while Japan’s renewable energy market grew the fastest.

Bayer Boosts Production Capacity In China

Bayer Boosts Production Capacity In China

Bayer’s US$139 million investment will make the Beijing site their largest pharmaceuticals packaging facility in China.

IBM To Spend US$100 Million On Big Data Consulting Labs

IBM To Spend US$100 Million On Big Data Consulting Labs

IBM invests US$100 million to develop ten Interactive Experience labs around the world, including five in Asia.

Sun Pharma Acquires Ranbaxy To Form India’s Largest Pharma

Sun Pharma Acquires Ranbaxy To Form India’s Largest Pharma

The US$3.2 billion transaction will form the largest pharmaceutical company in India and the fifth largest specialty generics manufacturer in the world.

Vietnam’s First Optical Satellite Reports Success

Vietnam’s First Optical Satellite Reports Success

One year after its launch, the data from Vietnam’s VNREDSat-1 has contributed to the country’s safety and economy.

Takeda Receives NDA Approval For Influenza Vaccine

Takeda Receives NDA Approval For Influenza Vaccine

Developed using cell culture-based technology, Takeda’s H5N1 vaccine could help to strengthen Japan’s pandemic preparedness.